• CT:VQ™ contracted for research and evaluation at Stanford University ahead of FDA clearance
• Stanford's 3DQ Lab renews contract and upgrades subscription for 4DMedical imaging solutions
• Contract includes CT LVAS™ and IQ-UIP™ in addition to CT:VQ™ for internal research use

4DMedical Limited, a global leader in respiratory imaging technology, has announced a renewed and significantly expanded contract with Stanford University's 3D Quantitative Imaging Laboratory (3DQ Lab), one of the most respected and influential medical imaging innovation centres in the United States. Under the renewed one-year subscription agreement, Stanford has licensed a comprehensive suite of advanced image analysis products from 4DMedical, including CT Lung Ventilation Analysis Software (CT LVAS™), IQ-UIP™, and the addition of CT:VQ™ for internal research use. Significantly, Stanford has requested to include CT:VQ™, 4DMedical's contrast-free ventilation perfusion product, in the contract for research and evaluation ahead of expected FDA-clearance. This expanded contract is another validation of 4DMedical's strategic focus on delivering next-generation pulmonary imaging capabilities to meet urgent healthcare needs.

As 4DMedical continues to expand its U.S. footprint, partnerships with leading academic medical centres like Stanford play a pivotal role in supporting clinical validation, market readiness, and broader adoption of 4DMedical's unique functional and structural lung imaging solutions.